EP0502103A4 - Direct fibrinogen assay - Google Patents

Direct fibrinogen assay

Info

Publication number
EP0502103A4
EP0502103A4 EP19910900512 EP91900512A EP0502103A4 EP 0502103 A4 EP0502103 A4 EP 0502103A4 EP 19910900512 EP19910900512 EP 19910900512 EP 91900512 A EP91900512 A EP 91900512A EP 0502103 A4 EP0502103 A4 EP 0502103A4
Authority
EP
European Patent Office
Prior art keywords
direct
fibrinogen assay
fibrinogen
assay
direct fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910900512
Other languages
English (en)
Other versions
EP0502103A1 (en
Inventor
Julie Frances Hoffman
Janet Black Callahan
Charles Hermas Swope
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of EP0502103A1 publication Critical patent/EP0502103A1/en
Publication of EP0502103A4 publication Critical patent/EP0502103A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Plasma & Fusion (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP19910900512 1989-12-01 1990-11-30 Direct fibrinogen assay Withdrawn EP0502103A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44394889A 1989-12-01 1989-12-01
US443948 1995-05-18

Publications (2)

Publication Number Publication Date
EP0502103A1 EP0502103A1 (en) 1992-09-09
EP0502103A4 true EP0502103A4 (en) 1993-05-05

Family

ID=23762843

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910900512 Withdrawn EP0502103A4 (en) 1989-12-01 1990-11-30 Direct fibrinogen assay

Country Status (9)

Country Link
EP (1) EP0502103A4 (fi)
JP (1) JPH05503008A (fi)
KR (1) KR920704117A (fi)
AU (1) AU641459B2 (fi)
CA (1) CA2068221A1 (fi)
FI (1) FI922312A0 (fi)
IE (1) IE904244A1 (fi)
WO (1) WO1991008460A1 (fi)
ZA (1) ZA909564B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
WO2000046603A1 (en) 1999-02-04 2000-08-10 Akzo Nobel N.V. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
CN110257475B (zh) * 2019-06-28 2023-05-02 深圳市国赛生物技术有限公司 纤维蛋白原检测试剂及其制备方法及检测试剂制品

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432268A (en) * 1964-08-28 1969-03-11 Peter Unger Method and apparatus for testing cell suspensions
US3905769A (en) * 1974-02-28 1975-09-16 Bagley Wallace E Method and apparatus for measuring prothrombin time and the like
EP0059277A1 (en) * 1981-03-02 1982-09-08 J. & P. Coats, Limited Rapid quantative measurement of fibrinogen in blood plasma
EP0184242A2 (en) * 1984-11-27 1986-06-11 INSTRUMENTATION LABORATORY S.p.A. Method for measuring coagulation parameters

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US3833864A (en) * 1972-11-30 1974-09-03 R Kiess Digital direct reading colorimeter
US3861877A (en) * 1974-01-21 1975-01-21 Clinical Technology Inc Optical analysis of fluids
US3989382A (en) * 1975-01-22 1976-11-02 Bio-Data Corporation Platelet aggregation monitoring device
AT382971B (de) * 1981-06-16 1987-05-11 Hoffmann La Roche Verfahren und vorrichtung zur messung der blutgerinnungszeit
GB8426004D0 (en) * 1984-10-15 1984-11-21 Ortho Diagnostic Systems Inc Coagulation monitoring

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432268A (en) * 1964-08-28 1969-03-11 Peter Unger Method and apparatus for testing cell suspensions
US3905769A (en) * 1974-02-28 1975-09-16 Bagley Wallace E Method and apparatus for measuring prothrombin time and the like
EP0059277A1 (en) * 1981-03-02 1982-09-08 J. & P. Coats, Limited Rapid quantative measurement of fibrinogen in blood plasma
EP0184242A2 (en) * 1984-11-27 1986-06-11 INSTRUMENTATION LABORATORY S.p.A. Method for measuring coagulation parameters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9108460A1 *

Also Published As

Publication number Publication date
IE904244A1 (en) 1991-06-05
FI922312A (fi) 1992-05-21
EP0502103A1 (en) 1992-09-09
JPH05503008A (ja) 1993-05-27
FI922312A0 (fi) 1992-05-21
AU641459B2 (en) 1993-09-23
KR920704117A (ko) 1992-12-19
ZA909564B (en) 1992-11-25
AU6898391A (en) 1991-06-26
CA2068221A1 (en) 1991-06-02
WO1991008460A1 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
ZA902710B (en) Enzyme luminescence assay
EP0419831A3 (en) Substituted sulfonylaminoazoles
GB8910958D0 (en) Assay
GB8913474D0 (en) Assay method
ZA909564B (en) Direct fibrinogen assay
GB2239601B (en) Odontotherapeutical materials
EP0422369A3 (en) Substituted carbamoyltriazoles
EP0416363A3 (en) Modified polyarylenesulfides
GB8919411D0 (en) Assay method
GB2250026B (en) Assays using albumin-tetrazolium interaction
IL95678A0 (en) Novel alkanophenones
GB8727479D0 (en) Riboflavin-linked assay
EP0414067A3 (en) Substituted arylsulfonyl-aminoguanidinoazine
GB8820375D0 (en) Assay
GB8621495D0 (en) Assay
GB8900732D0 (en) Agents
GB8922909D0 (en) Assay method
GB8924112D0 (en) Assay pretreatment
GB8918223D0 (en) Assay
IL95679A0 (en) Novel alkanophenones
GB8922265D0 (en) Assay methods
GB8809899D0 (en) Assay
GB8924215D0 (en) Point mutation assay
GB8713418D0 (en) Assay
GB8707667D0 (en) Assay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920428

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AKZO NOBEL N.V.

17Q First examination report despatched

Effective date: 19950110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950822